Pune (Maharashtra) [India], January 12 (ANI): After the first consignment containing vials of coronavirus vaccine "Covishield" were dispatched from the Pune factory, Adar Poonawalla, CEO, Serum Institute of India on Tuesday termed it a historic moment and said the main challenge is to mak
New Delhi [India], January 12 (ANI): Ahead of the first phase of the COVID-19 vaccination drive scheduled to start from January 16, vaccine transportation has started from Pune to 13 locations across the country, Union Minister Hardeep Singh Puri said on Tuesday.
Ahmedabad (Gujarat) [India], January 12 (ANI): The first consignment of 2,76,000 doses of COVID-19 vaccine 'Covidshield' will arrive in Ahmedabad from Pune on Monday.
Pune (Maharashtra) [India], January 12 (ANI): The first consignment containing vials of Covishield vaccine were dispatched from the Serum Institute of India here in the early hours of Tuesday, ahead of the January 16 launch of the nationwide vaccination drive.
Pune (Maharashtra) [India] January 11 (ANI): As India is all set to start the massive inoculation drive against the COVID-19 outbreak, the Pune-based logistic firm Kool-ex Cold Chain is prepared to transport the vaccine vials from Serum Institute of India to other parts of the country.
New Delhi [India], January 11 (ANI): Serum Institute of India (SII) has received the purchase order from the Government of India and 11 million doses of vaccine, Covishield would be available at the price of Rs 200 per vial, said insiders at the SII on Monday.
Pune (Maharashtra) [India], January 7 (ANI): A biotech firm based in Nanded, Maharashtra, has filed a suit against Serum Institute of India at a commercial court in Pune for using the trademark 'Covishield' for COVID-19 vaccine being manufactured by it.
Pune/Hyderabad [India], January 5 (ANI): Serum Institute of India and Bharat Biotech jointly communicated their pledge on Tuesday for the smooth rollout of COVID-19 vaccines to India and the world.
New Delhi [India], January 4 (ANI): In its permission to Serum Institute of India for "manufacture for sale or distribution" of COVID-19 vaccine 'Covishield', the DGCI has said that the second dose should be administered between four to six weeks after the first dose and also noted that the
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
New Delhi [India], January 3 (ANI): Tahir Qadiry, Afghan Charge d'Affaires on Sunday hailed India's decision to grant emergency use to Serum Institute of India for their Covid-19 vaccine, named Covishield.
New Delhi [India], January 3 (ANI): Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said Serum Institute of India Chief Executive Officer Adar Poonawalla on Sunday.